Propanc Biopharma (PPCB) Stock Price

Propanc Biopharma Price

OTC·CLOSED
0.49
​
Market closed

Propanc Biopharma stock price

Access this data via the Eulerpool API

Propanc Biopharma business model & stock analysis

Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The company is headquartered in Melbourne, Victoria and currently employs 1 full-time employees. The company went IPO on 2012-06-15. The firm has developed a composite formulation of anti-cancer compounds, which together exert a range of effects designed to control or prevent tumors from recurring and spreading through the body. The firm's solution is to develop and commercialize a long-term therapy to prevent tumor recurrence and metastases. The company is developing pro-enzyme therapy for the treatment and prevention of the development of carcinomas from solid tumors. The firm's products include PRP and PRP-DCM. The firm's PRP is a formulation consisting of two pro-enzymes: trypsinogen and chymotrypsinogen, plus the enzyme amylase (1, 4-alpha-D-glucan glucanohydrolase). The pro-enzymes in PRP, typsinogen and chymotrypsinogen, exhibit specificity for tumor cells and not normal cells.

Frequently asked questions about Propanc Biopharma

Converted at the current exchange rate, the Propanc Biopharma share trades at 0.43 EUR (0.49 USD).

The revenue cannot currently be calculated for Propanc Biopharma.

The profit of Propanc Biopharma is -18.86 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Propanc Biopharma is currently -0.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Propanc Biopharma stock.

The P/S cannot be calculated for Propanc Biopharma currently.

The Eulerpool Quality Score for Propanc Biopharma is 2/10.

The ISIN of Propanc Biopharma is US74346N7012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Propanc Biopharma is A2QJDP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Propanc Biopharma is PPCB. The ticker symbol is used to trade Propanc Biopharma shares on the stock exchange.

Fair ValueTerminal
0.40 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website propanc.com
Country
Australia
Currency
USD
Initial public offering
Jun 15, 2012
ISIN
US74346N7012
Cusip
74346N404
Sedol
BLD4YN6
Market capitalization
679.98 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
0.04
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-199.61 %
Last updated Oct 11, 2026, 7:26 PM